QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab

Clinical trial NCT02384954 · TERMINATED

Trial details

NCT number: NCT02384954
Sponsor: Altor BioScience
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma

Start date: 2015-04-17
Primary completion: 2020-12-13
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.